| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| keynote 024 | 1.02 | 0.4 | 9732 | 4 | 11 |
| keynote | 0.15 | 0.2 | 2128 | 86 | 7 |
| 024 | 1.49 | 0.9 | 8917 | 51 | 3 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| keynote 024 | 1.54 | 0.1 | 2562 | 73 |
| keynote 024 5 year update | 0.73 | 0.1 | 7095 | 13 |
| keynote-024 trial | 0.15 | 0.2 | 1661 | 55 |
| keynote 024 os | 1.76 | 0.1 | 4966 | 69 |
| keynote 024 orr | 1.35 | 0.3 | 4462 | 52 |
| keynote 024 update | 1.88 | 0.2 | 3497 | 88 |
| keynote 024 pfs | 1.54 | 0.1 | 3499 | 25 |
| keynote 024 nejm | 0.19 | 1 | 3108 | 55 |
| keynote 024 042 | 0.76 | 0.6 | 9106 | 47 |
| keynote 024 protocol | 1.86 | 0.5 | 2736 | 44 |
| keynote 024 fda approval | 1.69 | 0.5 | 4917 | 89 |
| keynote 024 pembrolizumab | 0.27 | 0.7 | 7412 | 59 |
| keynote 024 clinical trial | 1.66 | 0.1 | 529 | 50 |
